Inari Medical Quarterly Balance Sheets Chart
Quarterly
|
Annual
Inari Medical Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||
| current assets | ||||||||||||||||||
| cash and cash equivalents | 41,141,000 | 70,125,000 | 66,707,000 | 38,597,000 | 89,182,000 | 57,837,000 | 56,562,000 | 60,222,000 | 83,528,000 | 79,724,000 | 186,556,000 | 92,752,000 | 81,158,000 | 91,322,000 | 102,903,000 | 114,229,000 | 167,988,000 | 194,836,000 |
| restricted cash | 67,000 | 67,000 | 500,000 | 611,000 | 50,000 | 50,000 | 50,000 | |||||||||||
| short-term investments in debt securities | 70,397,000 | 39,547,000 | 34,595,000 | 76,855,000 | 262,113,000 | 279,696,000 | 271,884,000 | 266,179,000 | 235,705,000 | 250,772,000 | 152,156,000 | |||||||
| accounts receivable | 84,403,000 | 81,631,000 | 78,621,000 | 70,119,000 | 69,595,000 | 63,128,000 | 55,719,000 | 58,611,000 | 54,059,000 | 49,171,000 | 44,950,000 | 42,351,000 | 38,916,000 | 31,497,000 | 31,304,000 | 28,008,000 | 20,837,000 | 15,392,000 |
| inventories | 55,210,000 | 49,359,000 | 44,650,000 | 42,900,000 | 40,227,000 | 38,984,000 | 36,499,000 | 32,581,000 | 29,670,000 | 26,674,000 | 23,828,000 | 21,053,000 | 19,499,000 | 18,112,000 | 13,665,000 | 10,597,000 | 7,195,000 | 5,620,000 |
| prepaid expenses and other current assets | 12,168,000 | 8,623,000 | 8,240,000 | 6,481,000 | 7,944,000 | 4,972,000 | 4,942,000 | 5,312,000 | 7,609,000 | 4,997,000 | 5,849,000 | 5,694,000 | 7,141,000 | 2,497,000 | 2,159,000 | 2,808,000 | 3,391,000 | 3,866,000 |
| total current assets | 263,386,000 | 249,352,000 | 233,313,000 | 235,563,000 | 469,061,000 | 444,617,000 | 425,606,000 | 422,905,000 | 410,571,000 | 411,338,000 | 413,339,000 | 245,198,000 | 228,150,000 | 228,172,000 | 221,277,000 | 205,673,000 | 199,461,000 | 219,764,000 |
| property and equipment | 24,098,000 | 23,005,000 | 20,761,000 | 20,929,000 | 21,243,000 | 21,063,000 | 21,245,000 | 21,655,000 | 21,191,000 | 20,076,000 | 18,153,000 | 16,471,000 | 14,748,000 | 10,827,000 | 6,584,000 | 7,498,000 | 5,476,000 | 4,176,000 |
| operating lease right-of-use assets | 48,301,000 | 48,824,000 | 47,610,000 | 48,407,000 | 49,065,000 | 49,857,000 | 50,599,000 | 50,703,000 | 49,951,000 | 46,653,000 | 46,401,000 | 44,909,000 | 42,855,000 | 868,000 | 1,047,000 | |||
| goodwill | 213,345,000 | 204,401,000 | 209,642,000 | 214,335,000 | ||||||||||||||
| intangible assets | 143,808,000 | 143,106,000 | 145,774,000 | 150,884,000 | ||||||||||||||
| deposits and other assets | 4,301,000 | 4,242,000 | 4,676,000 | 4,117,000 | 9,466,000 | 9,431,000 | 9,084,000 | 8,889,000 | 6,106,000 | 6,195,000 | 6,216,000 | 981,000 | 672,000 | 13,692,000 | 5,669,000 | 583,000 | 536,000 | 76,000 |
| total assets | 697,239,000 | 672,930,000 | 661,776,000 | 674,235,000 | 548,835,000 | 524,968,000 | 506,534,000 | 504,152,000 | 487,819,000 | 484,262,000 | 484,109,000 | 311,542,000 | 292,427,000 | 253,559,000 | 234,577,000 | 214,092,000 | 205,811,000 | 224,354,000 |
| liabilities and stockholders' equity | ||||||||||||||||||
| current liabilities | ||||||||||||||||||
| accounts payable | 15,523,000 | 16,375,000 | 12,026,000 | 10,577,000 | 10,091,000 | 7,240,000 | 7,352,000 | 7,659,000 | 6,035,000 | 4,748,000 | 6,066,000 | 6,541,000 | 5,083,000 | 10,319,000 | 5,518,000 | 3,047,000 | 3,533,000 | 2,294,000 |
| payroll-related accruals | 54,797,000 | 54,363,000 | 38,748,000 | 48,706,000 | 41,305,000 | 38,290,000 | 28,443,000 | 38,955,000 | 28,052,000 | 27,695,000 | 19,729,000 | 24,433,000 | 16,987,000 | 16,041,000 | 11,550,000 | 8,198,000 | 8,596,000 | 7,223,000 |
| accrued expenses and other current liabilities | 76,881,000 | 65,605,000 | 33,544,000 | 15,364,000 | 13,040,000 | 11,125,000 | 11,018,000 | 8,249,000 | 7,668,000 | 8,076,000 | 9,155,000 | 10,737,000 | 6,583,000 | 4,429,000 | 2,758,000 | 2,593,000 | 2,198,000 | 1,385,000 |
| operating lease liabilities, current portion | 1,579,000 | 1,918,000 | 1,719,000 | 1,692,000 | 1,630,000 | 1,583,000 | 1,527,000 | 1,311,000 | 588,000 | 465,000 | 630,000 | 802,000 | 857,000 | 793,000 | ||||
| total current liabilities | 148,780,000 | 138,261,000 | 86,037,000 | 76,339,000 | 66,066,000 | 58,238,000 | 48,340,000 | 56,174,000 | 42,343,000 | 40,984,000 | 35,580,000 | 42,513,000 | 29,510,000 | 31,582,000 | 20,615,000 | 13,838,000 | 14,327,000 | 10,902,000 |
| operating lease liabilities, noncurrent portion | 31,145,000 | 31,231,000 | 29,773,000 | 30,355,000 | 30,627,000 | 31,085,000 | 31,458,000 | 30,976,000 | 30,377,000 | 28,196,000 | 28,301,000 | 28,404,000 | 28,547,000 | 156,000 | ||||
| deferred tax liability | 36,748,000 | 35,126,000 | 35,395,000 | 36,231,000 | ||||||||||||||
| other long-term liability | 45,805,000 | 44,503,000 | 63,341,000 | 66,400,000 | 1,304,000 | 1,416,000 | 1,416,000 | |||||||||||
| total liabilities | 262,478,000 | 249,121,000 | 214,546,000 | 209,325,000 | 96,693,000 | 89,323,000 | 79,798,000 | 87,150,000 | 72,720,000 | 70,484,000 | 65,297,000 | 72,333,000 | 58,057,000 | 31,738,000 | 20,966,000 | 13,838,000 | 14,327,000 | 40,484,000 |
| commitments and contingencies | ||||||||||||||||||
| stockholders' equity | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of september 30, 2024 and december 31, 2023 | ||||||||||||||||||
| common stock | 58,000 | 58,000 | 58,000 | 58,000 | 58,000 | 57,000 | 57,000 | 54,000 | 53,000 | 53,000 | 53,000 | 50,000 | 50,000 | 50,000 | 50,000 | 49,000 | 49,000 | 48,000 |
| additional paid in capital | 543,961,000 | 528,624,000 | 518,338,000 | 504,453,000 | 497,063,000 | 483,752,000 | 475,754,000 | 462,949,000 | 457,043,000 | 445,807,000 | 440,238,000 | 257,144,000 | 253,256,000 | 237,764,000 | 233,673,000 | 227,624,000 | 225,843,000 | 224,726,000 |
| accumulated other comprehensive income | 13,145,000 | -837,000 | 1,522,000 | 8,885,000 | -1,158,000 | -1,181,000 | -7,000 | 849,000 | -402,000 | -246,000 | -107,000 | -158,000 | 4,000 | |||||
| accumulated deficit | -122,403,000 | -104,036,000 | -72,688,000 | -48,486,000 | -43,821,000 | -46,983,000 | -49,068,000 | -46,850,000 | -41,052,000 | -30,899,000 | -20,712,000 | -17,583,000 | -18,690,000 | -15,886,000 | -19,954,000 | -27,423,000 | -34,408,000 | -40,904,000 |
| total stockholders' equity | 434,761,000 | 423,809,000 | 447,230,000 | 464,910,000 | 452,142,000 | 435,645,000 | 426,736,000 | 417,002,000 | 415,099,000 | 413,778,000 | 418,812,000 | 239,209,000 | 234,370,000 | 221,821,000 | 213,611,000 | 200,254,000 | 191,484,000 | 183,870,000 |
| total liabilities and stockholders' equity | 697,239,000 | 672,930,000 | 661,776,000 | 674,235,000 | 548,835,000 | 524,968,000 | 506,534,000 | 504,152,000 | 487,819,000 | 484,262,000 | 484,109,000 | 311,542,000 | 292,427,000 | 253,559,000 | 234,577,000 | |||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of june 30, 2024 and december 31, 2023 | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of march 31, 2024 and december 31, 2023 | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of december 31, 2023 and 2022 | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of september 30, 2023 and december 31, 2022 | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of june 30, 2023 and december 31, 2022 | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of march 31, 2023 and december 31, 2022 | ||||||||||||||||||
| long-term investments in debt securities | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of december 31, 2022 and 2021 | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of september 30, 2022 and december 31, 2021 | ||||||||||||||||||
| accumulated other comprehensive loss | -945,000 | -1,183,000 | -767,000 | |||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of june 30, 2022 and december 31, 2021 | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of march 31, 2022 and december 31, 2021 | ||||||||||||||||||
| short-term investments | 83,348,000 | 81,436,000 | 84,744,000 | 71,246,000 | 49,981,000 | |||||||||||||
| long-term investments | 3,983,000 | 6,002,000 | ||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of december 31, 2021 and december 31, 2020 | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of september 30, 2021 and december 31, 2020 | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of june 30, 2021 and december 31, 2020 | ||||||||||||||||||
| lease liabilities, current portion | 789,000 | |||||||||||||||||
| lease liabilities, noncurrent portion | 351,000 | |||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of march 31, 2021 and december 31, 2020 | ||||||||||||||||||
| liabilities, mezzanine equity and stockholders' equity | ||||||||||||||||||
| notes payable | 29,582,000 | |||||||||||||||||
| warrant liabilities | ||||||||||||||||||
| mezzanine equity | ||||||||||||||||||
| redeemable convertible preferred stock | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of december 31, 2020; no shares authorized, issued, and outstanding as of december 31, 2019 | ||||||||||||||||||
| total liabilities, mezzanine equity and stockholders' equity | 214,092,000 | 205,811,000 | 224,354,000 | |||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of september 30, 2020; no shares authorized, issued, and outstanding as of december 31, 2019 | ||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding at june 30, 2020; no shares authorized, issued, and outstanding at december 31, 2019 |
We provide you with 20 years of balance sheets for Inari Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Inari Medical. Explore the full financial landscape of Inari Medical stock with our expertly curated balance sheets.
The information provided in this report about Inari Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.